[1]Locationinpatent:experimentalpartPeng,Chi-Chi;Cape,JonathanL.;Rushmore,Tom;Crouch,GregoryJ.;Jones,JeffreyP.[JournalofMedicinalChemistry,2008,vol.51,#24,p.8000-8011]
[1]Patent:WO2017/184547,2017,A1.Locationinpatent:Paragraph00373
126088-20-8
107027-39-4
103914-61-0
7482-91-9
5110-02-1
43071-47-2
99548-56-8 | Methyl 2-bromo-6-methylbenzoate | AA006NK5 | MFCD09260938
942069-45-6 | 2-(4-Bromo-3,5-dichlorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | AA006OJ3 | MFCD12405328
91219-69-1 | Hydroxylamine, O,O'-1,8-octanediylbis- | AA006PF3 | MFCD31690494
90389-89-2 | [(3-Chlorophenyl)methyl](propan-2-yl)amine | AA006QKJ | MFCD06408101
90323-30-1 | 1-Methyl-6-nitroquinoxaline-2,3(1H,4H)-dione | AA006RNS | MFCD00956877
65340-76-3 | 8-Iodoquinolin-4-amine | AA006ST7 | MFCD06658313
98135-75-2 | Cyclobutanol, 1-ethynyl- | AA006TG6 | MFCD20485796
5169-93-7 | 2-Piperazin-2-yl-ethanol-2hcl | AA006U2G | MFCD12755993
52333-42-3 | 7-Bromopyrido[2,3-b]pyrazine | AA006UQU | MFCD01105748
2587-47-5 | Cyclotetrasilazane,1,2,3,4,5,6,7,8-octamethyl- | AA006VCJ | MFCD01735859